Integrated Platform for Regenerative Medicine and Cell Manufacturing
LIS TECH has long been dedicated to introducing advanced global biotechnology solutions, with a continued focus on regenerative medicine and cell therapy applications. At the 2026 BIO Asia–Taiwan Exhibition, the company will emphasize “cell bioprocessing and the industrialization of regenerative medicine,” showcasing integrated solutions across 3D cell culture, tissue engineering, bioprinting, scalable cell manufacturing, and exosome-related bioprocess technologies.

IK INABATA and ESCO: Advancing Cell Culture and Scale-Up Manufacturing
To address the growing demand for industrialized cell therapy, the IK INABATA Solallis Bio™ series will be featured, including MSC-specific culture media, EV (exosome) collection media, and organic solvent-free cryopreservation solutions designed to improve stability and safety in cell handling processes.

In addition, the ESCO BelloCell system, based on the proprietary “Tide Motion” culture principle, will be presented. Its wave-motion mechanism and efficient gas exchange design provide a low-shear, high-oxygen environment, enabling improved cell growth efficiency and consistency—serving as a critical foundation for large-scale cell manufacturing.

ExoPERT and Genimer™ Technology: Integrated Exosome Bioprocessing Workflow
Exosomes are emerging as a key focus in regenerative medicine and cell therapy research.

The ExoPERT exosome purification platform from Korea includes the Exo-i purification column and the ExoTractor automated isolation system. These technologies improve exosome isolation efficiency while enhancing process reproducibility and stability, resulting in highly purified exosome preparations suitable for downstream applications.

In parallel, collaboration with GeniCore Biotech enables Genimer™ aptamer-based tools for exosome characterization, including markers such as CD9, CD63, and CD81, supporting applications from basic research to process development.

SUMITOMO BAKELITE Sbio™: 3D Cell Culture and Organoid Platform
The SUMITOMO BAKELITE Sbio™ 3D culture platform provides highly consistent spheroid and organoid models.

PrimeSurface™ 3D culture plates enable uniform spheroid formation, improving the reliability of drug screening applications. Meanwhile, the BioStellar™ organoid platform supports multi-cell co-culture systems, enhancing physiological relevance by more accurately mimicking in vivo tissue microenvironments.

ROKIT Healthcare: 3D Bioprinting Platform
The Dr. INVIVO 3D bioprinting system from ROKIT Healthcare offers multi-material printing capabilities with high process stability. It is applicable to regenerative medicine research, tissue engineering, and personalized medicine development, accelerating the translation of innovative research into clinical applications.

Toward the Industrialization of Regenerative Medicine
By integrating 3D cell culture, tissue engineering, bioprinting, scalable cell manufacturing, and exosome technologies, LIS TECH is building a comprehensive regenerative medicine and bioprocessing platform.

The company will continue to introduce cutting-edge global technologies to support Taiwan’s biotech industry in accelerating R&D translation and advancing toward industrial-scale applications.

Contact Information
LIS TECH CO., LTD.
Website: https://www.lis-bio.com/zh-TW
Tel: +886-2-2228-8950
Email: info@lis-tek.com
Booth No.: M1231